Firebrick Pharma Ltd | ABN 64 157 765 896 | L14, 333 Collins St. Melbourne, VIC, 3000, Australia P: 1300 301 874 | W: firebrickpharma.com 15 September 2026 ASX Announcement Notice of Annual General Meeting and Closing Date for Director Nominations Firebrick Pharma Limited (ASX: FRE) ...
Firebrick Pharma: Notice of AGM and Closing Date for Director Nominations
Filed with ASX · · 1 page · English
Summary by 6ix AI
Firebrick Pharma Limited has announced the details for its upcoming Annual General Meeting, which will be held virtually. The meeting is scheduled for a specific time and date, allowing shareholders to participate online. Additionally, the company has set a closing date for director nominations, which must be submitted in writing by a specified time. This announcement was authorized by the Executive Chairman of Firebrick Pharma Limited.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Firebrick Pharma Limited on 6ix
Earlier from Firebrick Pharma
- Appendix 4E and Annual Report 30 June 2026
- Appendix 4G
- Corporate Governance Statement
- Cleansing Notice
- Application for quotation of securities - FRE
Later from Firebrick Pharma
- Firebrick receives $293,000 R&D Tax Incentive
- Firebrick announces USA Retail Launch Plan
- Firebrick Investor Update Presentation
- Firebrick Secures $732k in Strategic Investments
- Proposed issue of securities - FRE
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma